New tests launched in November
Share this:
In November 2020, Mayo Clinic Laboratories announced six new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
The new tests that launched in November 2020 by Mayo Clinic Laboratories:
- S-(2-Succinyl)-Cysteine (2SC) Immunostain, Technical Component Only (Mayo ID): 2SC - Identification of high levels of aberrant S-(2-succino)-cysteine (2SC), secondary to pathogenic alterations of the fumarate hydratase (FH) gene
- Arsenic Speciation, Random, Urine (Mayo ID: SPAS) - Diagnosis of arsenic intoxication in random urine specimens
- Cytokine Panel, Plasma (Mayo ID: CYPAN) - Understanding the etiology of infectious or chronic inflammatory diseases, when used in conjunction with clinical information and other laboratory testing
- Dendritic Cell and Monocyte Enumeration, Blood (Mayo ID: DCME) - Aiding in the diagnosis of patients suspected of defects in innate immunity, particularly those involving monocyte and dendritic cell development[SRF1]
- Galactose-Alpha-1,3-Galactose (Alpha-Gal), IgE, Serum (Mayo ID: ALGAL) - As an aid in diagnosis of an IgE mediated hypersensitivity allergy to non-primate mammalian red meat or meat-derived products such as beef, pork, venison, and meat-derived products (eg, gelatin)
- Galactose-Alpha-1,3-Galactose (Alpha-Gal) Mammalian Meat Allergy Profile, Serum (Mayo ID: APGAL) - As an aid in diagnosis of an IgE mediated hypersensitivity allergy to non-primate mammalian red meat or meat-derived products, such as beef, pork, venison, and meat-derived products such as gelatin via allergen profile testing
In addition to this test, the department also announced several test changes. Click the links below to view test changes announced by Mayo Clinic Laboratories:
